Prognostic factors in cystic fibrosis - the impact of antibody response and platelet activation

Ulrika Lindberg

Prognostic factors in cystic fibrosis - the impact of antibody response and platelet activation

Respiratory Medicine, Allergology, and Palliative Medicine

Research output: Thesis › Doctoral Thesis (compilation)

858 Downloads (Pure)

Original language	English
Qualification	Doctor
Awarding Institution	Respiratory Medicine, Allergology, and Palliative Medicine
Supervisors/Advisors	Segelmark, Mårten, Supervisor Hellmark, Thomas, Supervisor
Award date	2017 Feb 3
Place of Publication	Lund
Publisher	Lund University: Faculty of Medicine
ISBN (Print)	978-91-7619-407-2
Publication status	Published - 2017

Bibliographical note

Defence details
Date: 2017-02-03
Time: 09:00
Place: Belfragesalen, BMC D15, Klinikgatan 32, Lund.
External reviewer(s)
Name: Hjelte, Lena
Title: professor
Affiliation: Stockholm
---
ISSN: 1652-8220
Lund University, Faculty of Medicine Doctoral Dissertation Series 2017:26

Subject classification (UKÄ)

Medical and Health Sciences

Access to Document

spik ex-1Final published version, 2.4 MB

2 Article

BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
Lindberg, U., Carlsson, M., Hellmark, T. & Segelmark, M., 2015, In: Journal of Immunology Research. 2015, 947934.
Research output: Contribution to journal › Article › peer-review

Open Access
File
187 Downloads (Pure)
BPI-ANCA and Long-Term Prognosis among 46 Adult CF Patients: A Prospective 10-Year Follow-Up Study.
Lindberg, U., Carlsson, M., Löfdahl, C.-G. & Segelmark, M., 2012, In: Clinical & Developmental Immunology. 2012, 370107.
Research output: Contribution to journal › Article › peer-review

File
220 Downloads (Pure)

Cite this

@phdthesis{2af9cc3821f646cfa33ca18fe8129c3f,

title = "Prognostic factors in cystic fibrosis - the impact of antibody response and platelet activation",

author = "Ulrika Lindberg",

note = "Defence details Date: 2017-02-03 Time: 09:00 Place: Belfragesalen, BMC D15, Klinikgatan 32, Lund. External reviewer(s) Name: Hjelte, Lena Title: professor Affiliation: Stockholm --- ISSN: 1652-8220 Lund University, Faculty of Medicine Doctoral Dissertation Series 2017:26",

year = "2017",

language = "English",

isbn = "978-91-7619-407-2",

publisher = "Lund University: Faculty of Medicine",

type = "Doctoral Thesis (compilation)",

school = "Respiratory Medicine, Allergology, and Palliative Medicine",

}

TY - THES

T1 - Prognostic factors in cystic fibrosis - the impact of antibody response and platelet activation

AU - Lindberg, Ulrika

N1 - Defence details Date: 2017-02-03 Time: 09:00 Place: Belfragesalen, BMC D15, Klinikgatan 32, Lund. External reviewer(s) Name: Hjelte, Lena Title: professor Affiliation: Stockholm --- ISSN: 1652-8220 Lund University, Faculty of Medicine Doctoral Dissertation Series 2017:26

PY - 2017

Y1 - 2017

M3 - Doctoral Thesis (compilation)

SN - 978-91-7619-407-2

PB - Lund University: Faculty of Medicine

CY - Lund

ER -

Prognostic factors in cystic fibrosis - the impact of antibody response and platelet activation

Bibliographical note

Subject classification (UKÄ)

Access to Document

Research output

BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.

BPI-ANCA and Long-Term Prognosis among 46 Adult CF Patients: A Prospective 10-Year Follow-Up Study.

Cite this